Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NORDIC PHYTOTECH ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 3.7% 3.7%   Bankruptcy risk   6.7% 10.3% 7.6% 11.2% 9.9% 12.2% 16.4% 16.4%   Credit score (0-100)   37 25 32 20 24 18 11 11   Credit rating   BBB BB BB BB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   230 318 246 272 206 -75.3 0.0 0.0   EBITDA   47.9 135 63.2 66.0 22.5 -121 0.0 0.0   EBIT   47.9 135 63.2 66.0 22.5 -121 0.0 0.0   Pre-tax profit (PTP)   3.8 59.4 61.4 57.6 -38.8 -145.2 0.0 0.0   Net earnings   2.9 46.4 47.8 44.8 -38.8 -145.2 0.0 0.0   Pre-tax profit without non-rec. items   3.8 59.4 61.4 57.6 -38.8 -145 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   200 247 295 339 301 155 75.5 75.5   Interest-bearing liabilities   617 655 0.0 0.0 448 572 0.0 0.0   Balance sheet total (assets)   1,095 959 1,038 833 749 767 75.5 75.5   Net Debt   437 -8.0 -421 -681 -42.7 299 -75.5 -75.5     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   230 318 246 272 206 -75.3 0.0 0.0   Gross profit growth   -22.3% 37.9% -22.6% 10.6% -24.4% 0.0% 0.0% 0.0%   Employees   0 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,095 959 1,038 833 749 767 75 75   Balance sheet change%   15.8% -12.4% 8.3% -19.8% -10.1% 2.4% -90.2% 0.0%   Added value   47.9 135.2 63.2 66.0 22.5 -121.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   20.8% 42.6% 25.7% 24.3% 10.9% 161.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.7% 13.2% 10.4% 9.6% 3.4% -15.2% 0.0% 0.0%   ROI %   6.0% 15.7% 17.4% 28.2% 5.0% -15.6% 0.0% 0.0%   ROE %   1.5% 20.7% 17.7% 14.1% -12.1% -63.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   18.3% 25.7% 28.4% 40.8% 40.2% 20.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   912.6% -5.9% -666.1% -1,031.7% -190.1% -246.9% 0.0% 0.0%   Gearing %   307.6% 265.2% 0.0% 0.0% 148.9% 367.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.4% 11.9% 13.0% 0.0% 29.4% 5.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 0.9 1.1 1.4 1.1 0.9 0.0 0.0   Current Ratio   1.2 1.3 1.4 1.7 1.7 1.3 0.0 0.0   Cash and cash equivalent   179.5 662.6 421.0 681.3 490.4 272.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   200.5 246.8 294.6 339.5 300.7 155.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 135 63 66 22 -121 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 135 63 66 22 -121 0 0   EBIT / employee   0 135 63 66 22 -121 0 0   Net earnings / employee   0 46 48 45 -39 -145 0 0